Novel bismuth compounds have in vitro activity against Helicobacter pylori

FEMS Microbiology Letters

Volumn 157, Issue 2, 1997, Pages 229-232

  Midolo, P D ^a   Norton, A ^b   Von Itzstein, M ^b   Lambert, J R ^c  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c PENINSULA HEALTH   (Australia)

Author keywords

Bismuth; H. pylori; Sialic acid inhibitor

Indexed keywords

BISMUTH CITRATE; BISMUTH DERIVATIVE; N ACETYLNEURAMINIC ACID DERIVATIVE;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HELICOBACTER PYLORI; NONHUMAN; PRIORITY JOURNAL;

HELICOBACTER PYLORI;

EID: 0031573767     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(97)00479-5     Document Type: Article

References (17)

1. Glupczynski, Y., Goutier, S., Van den Borre, C., Butzler, J.P. and Burette, A. (1995) Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium from 1989 to 1994. Gut 37 (Suppl. 1), A56.
2. Midolo, P.D., Korman, M.G., Turnidge, J.D. and Lambert, J.R. (1996) Helicobacter pylori resistance to tetracycline. Lancet 347, 1194-1195.
3. Coudron, P.E. and Stratton, C.W. (1995) Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, done alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob. Agents Chemother. 39, 66-69.
4. Lambert, J.R. and Midolo, P. (1997) The actions of bismuth in the treatment of H. pylori infection. Ailment Pharmacol. Ther. 11 (Suppl. 1), 27-34.
5. Auge, C. and Gautheron, C. (1987) The use of an immobilised aldolase in the first synthesis of a natural deaminated neuaminic acid. J. Chem. Soc. Chem. Commun. 859-860.
6. Berdnarski, M.D., Chenault, H.K., Simon, E.S. and Whitesides, G.M. (1987) Membrane-enclosed enzymatic catalysis (MEEC): A useful, practical new method for the manipulation of enzymes in organic synthesis. J. Am. Chem. Soc. 109, 1283-1285.
7. Asato, E., Driessen, D.L., Graaff, R.A., Hulsbergen, F.B. and Reedijk, J. (1991) Synthesis, structure and spectroscopic properties of bismuth citrate compounds. Inorg. Chem. 30, 4210-4218.
8. Pounder, R.E., Bailey, R., Louw, J.A., Ohlin, B., Dixon, M.F., Quirke, P. and Duggan, A.E. (1995) GR122311X (ranitidine bismuth citrate) with clarithromycin for the eradication of H. pylori. Gut 37 (Suppl. 1), A42.
9. Reijers, M.H., Noch, L.A. and Tytgat, G.N. (1994) Evaluation of H. pylori eradication with bismuth sucrulfate. Ailment Pharmacol. Ther. 8, 351-352.
10. Le Blanc, R., Van Zanten, S., Bunford, N., Agee, L. and Leddin, D.J. (1995) The efficacy of novel bismuth compounds in healing gastric ulceration in the rat varies with chemical structure-implications for H. pylori treatment. Gastroenterology 108, A860.
11. Goodwin, C.S., Armstrong, J.A. and Cooper, M. (1991) Colloidal bismuth subcitrate inhibits the adherence of H. pylori to epithelial cells. Ital. J. Gastroenterol. 23 (Suppl. 2), 40.
12. Moran, A.P., Valkonen, K. and Wadstrom, T. (1995) Identification of the lectin-like laminin binding protein of Helicobacter pylori. Gut 37 (Suppl. 1), A2.
13. Marshall, B.J. (1991) Virulence and pathogenicity of Helicobacter pylori. J. Gastroenterol. Hepatol. 6, 121-124.
14. von Itzstein, M., Wu, W-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Van Phan, T., Smythe, M.L., White, H.F., Oliver, S.W., Coleman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M. and Penn, C.R. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
15. von Itzstein, M., Dyason, J.C., Oliver, S.W., White, H.F., Wu, W-Y., Kok, G.B. and Pegg, M.S. (1996) A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. J. Med. Chem. 39, 388-391.
16. Holzer, C.T., von Itzsein, M., Jin, B., Pegg, M.S., Stewart, W.S. and Wu, W-Y. (1993) Inhibition of sialidases from viral, bacterial, and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position. Glycoconjug. J. 10, 40-45.
17. Hayden, F.G., Treanor, J.J., Betts, R.F., Lobo, M., Esinhart, J.D. and Hussey, E.K. (1996) Saftey and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 274, 295-299.